scispace - formally typeset
E

Evelina Gatti

Researcher at Aix-Marseille University

Publications -  68
Citations -  15090

Evelina Gatti is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Antigen processing & Innate immune system. The author has an hindex of 37, co-authored 67 publications receiving 13184 citations. Previous affiliations of Evelina Gatti include University of Aveiro & Ludwig Institute for Cancer Research.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Developmental regulation of MHC class II transport in mouse dendritic cells

TL;DR: It is found that although early DCs could not present antigen immediately after uptake, efficient presentation of the previously internalized antigen occurred after maturation, 24–48 hours later, a property crucial to their role in immune surveillance.
Journal ArticleDOI

Suppression of eIF2α kinases alleviates Alzheimer's disease–related plasticity and memory deficits

TL;DR: The findings implicate aberrant eIF2α phosphorylation as a previously unidentified molecular mechanism underlying Alzheimer's disease–related synaptic pathophysioloy and memory dysfunction and suggest that PERK and GCN2 are potential therapeutic targets for treatment of individuals with Alzheimer’s disease.